Logo
L

LABORATORIOS SILANES SA DE CV

Established in 1943, Silanes is a pharmaceutical lab. Their therapeutic areas include Diabetes, Cardiovascular, Gastroenterology, and more. With a global presence, Silanes is based out of Mexico City, Mexico.
Country/AreaMexico
Company Emailenrique@silanes.com.mx
IndustryHealthcarePharmaceuticals
Company website
Company phone+52 5554883700
Established1943
Company Revenue$12,754,000
Number of employees97
SIC Code28283
NAICS Code32325
Main ProductsNunca más sin ellosEstudios ClínicosResponsabilidad SocialFarmacovigilanciaDesarrollo de NegociosÁreas TerapéuticasDesarrollo de Productos
http://www.linkedin.com/company/laboratorios-silaneshttp://www.twitter.com/lab_silaneshttp://www.facebook.com/laboratoriosilanes

Company News

Rare Disease Therapeutics, Inc. Announces New Expanded FDA Approved Indication for Antivenom ANAVIP® for Treatment of North American Pit Viper Envenomation
FRANKLIN, Tenn.--(BUSINESS WIRE)--Rare Disease Therapeutics Announces New Expanded FDA Approved Indication for Antivenom ANAVIP® for Treatment of North American Pit Viper Envenomation

Web Summary

Q1: What is the company name and its location?
A1: The company name is Laboratorios SILANES SA DE CV, but unfortunately, the text does not provide the exact address of the company.

Q2: What products does the company develop and sell?
A2: According to the text, Laboratorios SILANES develops and sells a wide range of pharmaceutical products, including medications for conditions such as hypertension, diabetes, dislipidemia, and obesity. They also have lines of products for antituberculosos, vitamins, pain relief, and preventive treatments for asthma.

Q3: What is the company's focus in terms of research and development?
A3: The company focuses on developing new forms of pharmaceuticals and creating or improving medical devices to offer competitive advantages in both competitive and niche markets. They also invest in infrastructure and technology to meet growing demand for products that address real health needs.

Q4: How many patents has the company obtained?
A4: According to the text, Laboratorios SILANES has obtained a total of 150 patents, including 11 national patents, 99 foreign patents, 311 registered trademarks (both national and international), and 8 additional patent applications.

Q5: What is the company's commitment to patient care?
A5: The company emphasizes its commitment to putting patients at the center of all its decisions. They offer tools and benefits for healthcare professionals to provide better care for their patients, such as developing products that improve health outcomes.

Q6: How does the company handle safety concerns related to its products?
A6: Laboratorios SILANES prioritizes safety and has a system in place for reporting and managing adverse events or reactions to its products. They also offer resources for patients and healthcare professionals to report any concerns.

Q7: What is the company's approach to innovation and continuous improvement?
A7: The company continuously innovates and improves its development processes, including identifying risks and developing strategies to mitigate them. This includes investing in new technologies and infrastructure to stay ahead of growing demand for high-quality products.

Q8: How does the company ensure transparency and accountability in its operations?
A8: Laboratorios SILANES has a clear policy on cookies and data collection, allowing users to consent or opt-out of cookie usage. They also have an Aviso de privacidad (Privacy Notice) that outlines their commitment to protecting user information.
Customs Data
As a purchaser
As a Supplier
Disable_icon
Get the Whole details
DisableData_png
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Disable_icon
Get the Whole details
DisableContact_png